Skip to content

13F-HR filed by ACUTA CAPITAL PARTNERS, LLC

ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2016-06-30, filed 2016-08-15, with 65 holding rows worth $208,097,000.

Accession
0001493152-16-012395
Filed
2016-08-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2016

A holdings report, 65 entries on the cover page, a total value of $208,097,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $208,097,000 with VALUE read as thousands by filing date, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Lion Biotechnologies53619R102COM3,232,416$26,183,000thousands by filing date
VERACYTE INC COM92337F107Stock3,187,607$16,034,000thousands by filing date
IRIDEX CORP462684101COM1,011,871$14,966,000thousands by filing date
NEURODERM LTDM74231107ORD SHS634,000$10,303,000thousands by filing date
IMMUNOMEDICS INC452907108COM4,200,000$9,744,000thousands by filing date
RRSAT GLOBAL COMM NTWRK LTDM8183P102SHS611,818$7,996,000thousands by filing date
EVERYDAY HEALTH INC COM300415106Stock945,000$7,447,000thousands by filing date
CAS MED SYS INC124769209COM3,500,602$6,441,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM1,161,545$6,342,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR472,800$6,274,000thousands by filing date
iShares Russell 2000 ETF464287655SHS50,000$5,749,000thousands by filing dateput
EDGE THERAPEUTICS INC279870109COM530,000$5,358,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM64,000$4,979,000thousands by filing date
DERMIRA INC24983L104COM170,000$4,973,000thousands by filing date
AKEBIA THERAPEUTICS INC00972D105COMMON STOCK600,000$4,488,000thousands by filing date
NABRIVA THERAPEUTICS AG62957M104SPONSORED ADR558,771$4,191,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS417,278$3,756,000thousands by filing date
IMMUNOMEDICS INC452907AK4NOTE 4.750 2/15,500,000$3,733,000thousands by filing dateprincipal
CEMPRA INC15130J109COM210,000$3,463,000thousands by filing date
INNOCOLL HLDGS PLCG4783X105SHS568,137$3,130,000thousands by filing date
MEDIVATION INC58501N101COM50,000$3,015,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM85,999$2,792,000thousands by filing date
TESARO INC881569107COM30,000$2,522,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM130,000$2,479,000thousands by filing date
MARVELL TECHNOLOGY GROUP LTDG5876H105ORD239,588$2,283,000thousands by filing date
INSULET CORP COM45784P101Stock75,000$2,268,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock220,000$2,169,000thousands by filing date
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock300,000$2,111,000thousands by filing date
ALLERGAN PLCG0177J108SHS8,500$1,964,000thousands by filing date
CYNAPSUS THERAPEUTICS INC23257Y859COM PAR NO PAR115,400$1,933,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM42,000$1,909,000thousands by filing date
PROGENICS PHARMACEUTICALS IN743187106COM448,885$1,894,000thousands by filing date
RETROPHIN INC761299106COM98,788$1,759,000thousands by filing date
ESSA PHARMA INC29668H104COM570,232$1,754,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK747,748$1,667,000thousands by filing date
ATRICURE INC04963C209COM112,923$1,596,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM80,000$1,526,000thousands by filing datecall
WEBMD HEALTH CORP94770V102COM25,000$1,453,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW140,969$1,338,000thousands by filing date
STONE ENERGY CORP COM NEW861642304Stock108,100$1,304,000thousands by filing dateput
GENOMIC HEALTH, INC.37244C101COM48,800$1,264,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM225,444$1,251,000thousands by filing date
IGNYTA INC451731103COM229,748$1,245,000thousands by filing date
ALIMERA SCIENCES INC016259103COM974,318$1,198,000thousands by filing date
UNIVERSAL DISPLAY CORP91347P105COM15,000$1,017,000thousands by filing date
RAPTOR PHARMACEUTICAL CORP75382F106COM174,708$938,000thousands by filing date
ONCOBIOLOGICS INC68235M105COM243,391$828,000thousands by filing date
SINOVAC BIOTECH LTDP8696W104SHS132,503$786,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM125,000$683,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK50,000$654,000thousands by filing date
BIOTELEMETRY INC090672106COM34,630$564,000thousands by filing date
AKARI THERAPEUTICS PLC00972G108ADR33,077$446,000thousands by filing date
CAREDX INC14167L103COM64,627$279,000thousands by filing date
TROVAGENE INC897238309COM52,000$236,000thousands by filing dateput
DEXTERA SURGICAL INC COM252366109CS128,958$232,000thousands by filing date
CYTRX CORP232828509COM PAR $.001100,000$223,000thousands by filing dateput
AUDIOCODES LTDM15342104ORD45,035$189,000thousands by filing date
RELYPSA INC759531106Common Stock10,000$185,000thousands by filing datecall
IMMUNOMEDICS INC452907108COM58,600$136,000thousands by filing datecall
COMBIMATRIX CORPORATION20009T501COM PAR47,431$136,000thousands by filing date
MANNKIND CORP56400P201COM90,000$104,000thousands by filing dateput
CHEMBIO DIAGNOSTICS163572209COM12,180$100,000thousands by filing date
ONCOBIOLOG-CW17A68235M113EQUITY WRT96,833$45,000thousands by filing date
ONCOBIOLOGICS INC68235M121*W EXP 05/18/20196,833$44,000thousands by filing date
PERNIX THERAPEUTICS HOLDINGS71426V108COM62,800$28,000thousands by filing dateput

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001493152-16-012395this filing2016-08-15acceptance time not in the bulk data set